Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 35 - Antineoplastic agents
Patents for A61P 35 - Antineoplastic agents (221,099)
12/2005
12/21/2005EP1276501B1 Method for treatment of tumors using photodynamic therapy
12/21/2005EP1265916B1 Therapeutic anti-cytomegalovirus compounds
12/21/2005EP1265859B1 Amidino compounds useful as nitric oxide synthase inhibitors
12/21/2005EP1223915B1 Dry powder compositions having improved dispersivity
12/21/2005EP1222200B1 Fusion protein between HPV-L1 and a peptide, capable of forming a VLP and that functions as a vehicle for introduction of a peptide in a cell and medical uses thereof
12/21/2005EP1218518B1 Dna polymerase lambda and uses thereof
12/21/2005EP1153928B1 2-methyl-3-butenyl-1-pyrophosphoric acid salts and agents for treating lymphocytes
12/21/2005EP1144431B1 16-hydroxyestratrienes as selective estrogens
12/21/2005EP0994947B1 Mu-1, member of the cytokine receptor family
12/21/2005EP0979235B1 Isolated nucleic acid molecule coding for tumor rejection antigen precursors mage-c1 and mage-c2 and uses thereof
12/21/2005EP0783573B1 Method of enhancing expression of mhc class i molecules bearing endogenous peptides
12/21/2005EP0698108B2 Adenoviral vectors of animal origin and use thereof in gene therapy
12/21/2005EP0680331B1 Recombinant virus immunotherapy
12/21/2005CN1711269A 4-amino-5-phenyl-7-cyclohexyl-pyrrolo[2,3-d]pyrimidine derivatives
12/21/2005CN1711266A Pyrimido compounds having antiproliferative activity
12/21/2005CN1711264A Pyrimido[4,5-d]pyrimidine derivatives with anticancer activity
12/21/2005CN1711260A Pyridopyrimidinone compounds, method for production thereof and medicaments comprising the same
12/21/2005CN1711258A Pyrimidine compounds
12/21/2005CN1711236A Nitroaniline-based alkylating agents and their use as prodrugs
12/21/2005CN1711235A New phenyl-naphthalene derivatives, and preparation method and drug containing same
12/21/2005CN1711106A Agents for the diagnosis and treatment of tumours that expose altered proteins on the cell surface
12/21/2005CN1711099A Extract with anti-tumor and anti-poisonous activity
12/21/2005CN1711094A Combination product of inhibitor of the SRC family of non-receptor tyrosine kinases and gemcitabine
12/21/2005CN1711090A Combination of a nitrogen mustard analogue and imatinib for the treatment of chronic lymphocytic leukemia
12/21/2005CN1711076A Combination cancer therapy with a GST-activated anticancer compound and another anticancer therapy
12/21/2005CN1711074A Liposomes
12/21/2005CN1232643C Nucleic acid vaccine
12/21/2005CN1232641C Modulator for function of receptor of TNF/NGF receptor family and other protein
12/21/2005CN1232539C Match of organic medicine and beta-cyclodextrin derivative and its preparing process
12/21/2005CN1232537C Heavy chain variable region single domain antibody reinforced fusion protein VH-LDP-AE
12/21/2005CN1232534C Heteroprotein of melanoma EPI (Mage-1, HLA-Al) and bacteriophage coat protein and its application
12/21/2005CN1232518C Bi-heterocyclic compounds with antitumour and chemosensitising activity
12/21/2005CN1232517C Anti-cancer active substance of cyathocline purpurea and separating and purifying method thereof
12/21/2005CN1232507C Growth hormone secretagogues
12/21/2005CN1232306C Adjustable controllable tumor living vaccine and its preparation method
12/21/2005CN1232303C Use of gene NMESI related to esophageal carcinoma and encoded polypeptide
12/21/2005CN1232299C Chinese medicinal composition for treating liver cancer
12/21/2005CN1232298C Medication for treating malignant tumor and preparation method
12/21/2005CN1232297C Jiangjie blood supplementing mixture and its application
12/21/2005CN1232270C Medicinal composition for treating liver cancer and pancreatic cancer and its preparing method
12/20/2005US6977298 Tricyclic inhibitors of poly(ADP-ribose) polymerases
12/20/2005US6977296 Human cervical cancer suppressor protein, polynucleotide encoding the protein, cell transformed with the polynucleotide and method for suppressing proliferation of cancer cell using the expression vector
12/20/2005US6977268 Diacid isoindoleine amide derivative
12/20/2005US6977264 For therapy and prophylaxis of obesity, diabetes
12/20/2005US6977263 Chemical compounds
12/20/2005US6977259 Quinoline derivatives and their use as aurora 2 kinase inhibitors
12/20/2005US6977256 Compounds and compositions as cathepsin S inhibitors
12/20/2005US6977255 8-Substituted 2-morpholinyl-4H-pyrido(1,2-a)pyrimidin-4-ones inhibitor of phosphoinositide (PI) 3- kinase, an enzyme that regulates platelet-adhesion (antithrombotic agent)
12/20/2005US6977252 Use of 1,4-benzothiazepine derivatives as drugs for overcoming resistance to anticancer drugs
12/20/2005US6977244 Inhibition of Bcl-2 protein expression by liposomal antisense oligodeoxynucleotides
12/20/2005US6977241 SH2 domain binding inhibitors
12/20/2005US6977169 Administering neuraminidase
12/20/2005US6977150 Process and compositions for peptide, protein and peptidomimetic synthesis
12/20/2005US6977147 Method of screening therapeutic or preventative agents for squamous epithelial cell carcinoma
12/20/2005US6977074 to an antigen by sustained release to the lymphatic system; cytotoxic T lymphocytes; immunization; drug delivery
12/20/2005US6977072 Unblocking immunization at a regional lymph node by: promoting differentiation and maturation of immature dendritic cells in a regional lymph node and; allowing presentation by resulting mature dendritic cells of antigen to T-cells
12/20/2005US6977071 Use for treatment of inflammatory diseases, HIV-infection, angiogenisis and hematopoiesis-related disorders;
12/20/2005US6977070 Buccal, polar and non-polar spray or capsule containing drugs for treating disorders of the central nervous system
12/20/2005CA2329703C Bicyclic pyrimidines and bicyclic 3,4-dihydropyrimidines as inhibitors of cellular proliferation
12/20/2005CA2328903C Compounds capable of cleaving double-stranded dna and method of utilization of the same
12/20/2005CA2321610C C-myc coding region determinant-binding protein (crd-bp)
12/20/2005CA2266319C Isolated nucleic acid molecule encoding cancer associated antigen, the antigen itself, and uses thereof
12/15/2005WO2005118811A1 Novel polypeptide useful for diagnosis and treatment of cancer
12/15/2005WO2005118777A2 Novel saccharothrix strain and antibiotics derived therefrom, i.e. mutactimycins and aldgamycins
12/15/2005WO2005118631A1 Novel protein complex and use thereof
12/15/2005WO2005118623A1 Method and composition for treating angiogenesis and for preventing cancer progression and metastasis comprising a prostate secretory protein (psp94) family member
12/15/2005WO2005118612A1 Cholesterol/bile acid/bile acid derivative-modified therapeutic anti-cancer drugs
12/15/2005WO2005118588A1 Fused heterocyclic compound
12/15/2005WO2005118584A2 Saframycin analogs as therapeutic agents in the treatment of cancer
12/15/2005WO2005118583A1 2, 5-dihydro-pyrazolo`4, 3-c!quinolin-4-ones as chk-1 inhibitors
12/15/2005WO2005118556A1 Propane-1,3-dione derivative or its salt
12/15/2005WO2005118543A1 Kinase inhibitor and use thereof
12/15/2005WO2005118071A2 Tetrahydropyridothiophenes
12/15/2005WO2005117999A2 Imaging and therapeutic agents targeting proteins expressed on endothelial cell surface
12/15/2005WO2005117986A2 Antibody drug conjugates and methods
12/15/2005WO2005117934A1 Sustained release composition
12/15/2005WO2005117890A2 Thienopyrimidines and thiazolopyrimidines for use in medicine
12/15/2005WO2005117878A1 Irinotecan preparation
12/15/2005WO2005117867A2 Monocyclic heterocycles as kinase inhibitors
12/15/2005WO2005070459A8 Method of continuing expression of vector repeatedly administered
12/15/2005WO2005065266A3 Di-substituted pyrrolotriazine compounds
12/15/2005WO2005007832A3 System for external control of oncolytic virus replication
12/15/2005WO2002083921A8 Nuleic acids and corresponding proteins useful in the detection and treatment of various cancers
12/15/2005US20050277773 Pyrrolopyrimidine derivatives
12/15/2005US20050277763 For cancer therapy
12/15/2005US20050277678 5-(4-Fluorophenyl)-1-(4-methylsulfoximinylphenyl)-3-trifluoromethyl-1H-pyrazole; prostaglandin and cyclooxygenase inhibitor; antiinflammatory, analgesic, and antipyretic agent
12/15/2005US20050277660 Novel tetrahydroquinoline derivatives
12/15/2005US20050277656 Combination comprising docetaxel and a CDK inhibitor
12/15/2005US20050277652 Hepatocyte growth factor receptor inhibitors; Antitumor agents, anticarcinogenic agents, angiogenesis inhibitors; pyrimidine derivatives like Pyrrolidine-1-carboxylic acid [6-(2-fluoro-4-{3-[2-(4-fluorophenyl)acetyl]thioureido}phenoxy)pyrimidin-4-yl]amide
12/15/2005US20050277627 Colchinol derivatives as vascular damaging agents
12/15/2005US20050277609 Immunostimulatory nucleic acid molecules
12/15/2005US20050277604 Immunostimulatory nucleic acid molecules
12/15/2005US20050277594 Polypeptide for the treatment of cancer and a method for preparation thereof
12/15/2005US20050277583 Histone deacetylase inhibitors and process for producing the same
12/15/2005US20050277118 Methods for identifying subjects at risk of melanoma and treatments thereof
12/15/2005US20050277112 Novel therapeutic processes for treating infectious agents using same epitope specific antigens, and useful compositions therefor
12/15/2005US20050276893 Method for producing fat and/or solids from beans and compositions containing polyphenols
12/15/2005US20050276866 Combination comprising a CDK inhibitor and cisplatin
12/15/2005US20050276822 cancer vaccines; grows as an epithelial, adherent monolayer culture; does not overexpress estrogen receptors; overexpresses her2/neu; sensitive in vitro to cyclophosphamide (4HC), etoposide and taxol; resistant in vitro to carboplatin; demonstrates karyotypic abnormalities
12/15/2005US20050276819 Helicobacter pylori CAI antigen
1 ... 1231 1232 1233 1234 1235 1236 1237 1238 1239 1240 1241 1242 1243 1244 1245 1246 1247 1248 1249 1250 1251 ... 2211